Linda C. Burkly - 24 Jul 2023 Form 4 Insider Report for Editas Medicine, Inc. (EDIT)

Role: EVP, CHIEF SCIENTIFIC OFFICER
Signature: /s/ Linda C. Burkly
Issuer symbol: EDIT
Transactions as of: 24 Jul 2023
Net transactions value: $0
Form type: 4
Filing time: 25 Jul 2023, 16:45:05 UTC
Next filing: 05 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EDIT	Common Stock	Award	$0	+45,167		$0.000000	45,167	24 Jul 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EDIT	Stock Option (right to buy)	Award	$0	+135,500		$0.000000	135,500	24 Jul 2023	Common Stock	135,500	$8.66	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years in equal yearly installments of one-fourth of the shares, with the first such installment to vest on July 24, 2024 continuing through July 24, 2027.
F2	This option was granted on July 24, 2023 and is scheduled to vest over four years, with 25% of the shares to vest on July 24, 2024 and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through July 24, 2027.